Oral capecitabine as an alternative to i. v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. - Scheithauer,W.; McKendrick,J.; Begbie,S. (Ann Oncol, 2003)